Plasma proteomics outpredicts HbA1c for 10-year cardiometabolic disease risk in Nature Metabolism study
EricTopol · x · 2026-11-16
An open-access Nature Metabolism study identifies plasma proteomic insulin-resistance signatures that predict 10-year incident disease risk better than current metrics like HbA1c, TG/HDL ratio, and LDL. Across 20+ conditions — type 2 diabetes, fatty liver, end-stage renal disease, heart failure, hypertension, dementias, and multiple cancers — the proteomic 'predicted M value' showed higher C-index in the test set, with large cohorts per disease (e.g., 898 diabetes cases, 3,551 hypertension cases).
More from Research
- Jon Barron's CVPR23 Talk Revisited: A 1950s Speed Forecast That Overestimated the Future — jon_barron · 2026-11-16
- Google opens SatWeave and PARDIG, the foundational datasets behind WeatherNext 3 — ymatias · 2026-11-16
- Anthropic: agent memory works best by forgetting selectively—notes beat 400+ archives 4x in Pokémon Red — The Decoder · 2026-11-16
- Hugging Face ships definitive fine-tuning guide and scripts for 3D model TRELLIS.2 — linoy_tsaban · 2026-11-16
- miHoYo's Gamer agent beats 95% of Honkai: Star Rail challenges, plays 30+ games — _akhaliq · 2026-11-16
- Lightwheel launches RoboFinals RL-Env: RL training envs from real industrial tasks with calibrated physics — chris_j_paxton · 2026-11-16